We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMS icon
2776
Fresenius Medical Care
FMS
$12.9B
$323K ﹤0.01%
14,976
+335
+2% +$8.13K
LMNR icon
2777
Limoneira
LMNR
$251M
$322K ﹤0.01%
21,051
+696
+3% +$10.6K
SIMO icon
2778
Silicon Motion
SIMO
$8.68B
$322K ﹤0.01%
6,290
-1,690
-21% -$96.1K
LYG icon
2779
Lloyds Banking Group
LYG
$91.3B
$322K ﹤0.01%
151,147
-1,655
-1% -$3.59K
TIMB icon
2780
TIM SA
TIMB
$8.8B
$321K ﹤0.01%
21,537
+3,215
+18% +$48.1K
CLAR icon
2781
Clarus
CLAR
$143M
$320K ﹤0.01%
42,319
+839
+2% +$6.72K
STRO icon
2782
Sutro Biopharma
STRO
$421M
$319K ﹤0.01%
9,190
+225
+3% +$9.8K
OVID icon
2783
Ovid Therapeutics
OVID
$491M
$318K ﹤0.01%
82,791
+4,023
+5% +$14.5K
REFI
2784
Chicago Atlantic Real Estate Finance
REFI
$261M
$318K ﹤0.01%
21,584
+1,232
+6% +$18.6K
BBCP icon
2785
Concrete Pumping Holdings
BBCP
$491M
$318K ﹤0.01%
37,029
+1,370
+4% +$11K
DB icon
2786
Deutsche Bank
DB
$71.5B
$316K ﹤0.01%
28,788
-560
-2% -$6.05K
ICVX
2787
DELISTED
Icosavax, Inc. Common Stock
ICVX
$316K ﹤0.01%
40,771
+1,385
+4% +$11.5K
TSVT
2788
DELISTED
2seventy bio
TSVT
$315K ﹤0.01%
80,456
+399
+0.5% +$2.62K
TAST
2789
DELISTED
Carrols Restaurant Group, Inc.
TAST
$315K ﹤0.01%
47,811
+1,906
+4% +$11.7K
PROK icon
2790
ProKidney
PROK
$337M
$314K ﹤0.01%
68,644
-8,779
-11% -$84K
VLGEA icon
2791
Village Super Market
VLGEA
$639M
$314K ﹤0.01%
13,882
+143
+1% +$3.3K
SFST icon
2792
Southern First Bancshares
SFST
$600M
$314K ﹤0.01%
11,650
+9
+0.1% +$250
SMR icon
2793
NuScale Power
SMR
$4.03B
$313K ﹤0.01%
63,834
+835
+1% +$5.5K
DSGR icon
2794
Distribution Solutions Group
DSGR
$1.61B
$311K ﹤0.01%
11,960
-1,110
-8% -$28.6K
ASRT
2795
DELISTED
Assertio
ASRT
$311K ﹤0.01%
8,094
+2,204
+37% +$129K
JMSB icon
2796
John Marshall Bancorp
JMSB
$329M
$311K ﹤0.01%
17,401
+152
+0.9% +$2.86K
RLGT icon
2797
Radiant Logistics
RLGT
$395M
$310K ﹤0.01%
54,890
-45,636
-45% -$310K
SEMR
2798
DELISTED
Semrush
SEMR
$309K ﹤0.01%
36,343
+2,102
+6% +$19.6K
DSKE
2799
DELISTED
Daseke, Inc. Common Stock
DSKE
$308K ﹤0.01%
59,970
+1,186
+2% +$7.16K
EHTH icon
2800
eHealth
EHTH
$43.9M
$306K ﹤0.01%
41,350
+3,246
+9% +$25.5K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.